Curaleaf Holdings (CURLF) Net Income towards Common Stockholders (QoQ) (2019 - 2026)
Curaleaf Holdings (CURLF) Net Income towards Common Stockholders (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 110.58% |
| Mar 31, 2026 | 98.13% |
| Dec 31, 2025 | -632.32% |
| Sep 30, 2025 | 28.83% |
| Jun 30, 2025 | 70.53% |
| Mar 31, 2025 | 9.86% |
| Dec 31, 2024 | -798.02% |
| Sep 30, 2024 | 226.86% |
| Jun 30, 2024 | -325.22% |
| Mar 31, 2024 | 100.01% |
| Dec 31, 2023 | -30,750.86% |
| Sep 30, 2023 | -227.87% |
| Jun 30, 2023 | 37.22% |
| Mar 31, 2023 | 85.42% |
| Dec 31, 2022 | -578.28% |
| Sep 30, 2022 | -182.77% |
| Jun 30, 2022 | -121.06% |
| Mar 31, 2022 | 507.80% |
| Dec 31, 2021 | -108.23% |
| Sep 30, 2021 | -17.18% |